Contraception
RSSArticles
-
Washington Watch: Will Congress move on abstinence-only efforts?
-
Emergency contraception is gaining momentum from local to national levels
-
‘Graying’ providers: Will abortion care be limited?
-
Empiric Vaginal Metronidazole in the Management of the ASCUS Pap Smear
-
Intraperitoneal Chemotherapy for Ovarian Carcinoma
-
MORE Data, MORE Questions
-
Pharmacology Watch: GlaxoSmithKline Withdraws Lymerix: Company ‘Cuts Losses’ on Controversial Lyme Disease Vaccine
-
Generic EC — One step closer to OTC status
The Food and Drug Administration is looking to generic versions of the levonorgestrel-based emergency contraception (EC) pill Plan B One-Step to submit applications for new labeling after the agency ruled the generic version can be sold on store shelves without restriction. -
Intrauterine contraception safe and effective in teens and adults
Results from a recent retrospective analysis indicate that similar to adults, intrauterine device (IUD) use in adolescents and nulliparous women is effective and associated with low rates of serious complications. -
Research stirs debate on mammography
Results of a new study indicate that annual mammography in women ages 40-59 does not reduce mortality from breast cancer beyond that of physical examination or usual care when adjuvant therapy for breast cancer is freely available.